Allurion Technologies Holdings Inc. has announced the publication of new long-term weight loss results from studies involving the Allurion Program. The findings, presented in publications, indicate that in a study of 522 patients, participants achieved an average weight loss of approximately 32 pounds at the time of balloon passage, with 95% of this weight loss maintained one year later. In a separate study involving 497 patients, the average weight loss was 14.3% of total body weight, with 86% of patients maintaining this weight loss one year after the initial treatment. These results highlight the potential of the Allurion Program in achieving and maintaining significant weight loss.